skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: Geneva Foundation Free Medical Journals at publisher websites remove Database: Journals@Ovid Open Access Journal Collection Rolling remove Database: NORA - Norwegian Open Research Archives remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer
LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer
Material Type:
Article 		Add to My Research

LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer

EMBO molecular medicine, 2016-09, Vol.8 (9), p.1052-1064 [Peer Reviewed Journal]

2016 The Authors. Published under the terms of the CC BY 4.0 license ;2016 The Authors. Published under the terms of the CC BY 4.0 license. ;COPYRIGHT 2016 John Wiley & Sons, Inc. ;info:eu-repo/semantics/openAccess ;ISSN: 1757-4676 ;ISSN: 1757-4684 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201606198 ;PMID: 27485121

Full text available

Citations Cited by
2
The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis
The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis
Material Type:
Article 		Add to My Research

The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis

Journal of cachexia, sarcopenia and muscle, 2017-10, Vol.8 (5), p.789-797 [Peer Reviewed Journal]

2017 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders ;2017 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders. ;2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;ISSN: 2190-5991 ;EISSN: 2190-6009 ;DOI: 10.1002/jcsm.12220 ;PMID: 28627024

Full text available

Citations Cited by
3
Health‐related quality of life in Norwegian adults with Fabry disease: Disease severity, pain, fatigue and psychological distress
Health‐related quality of life in Norwegian adults with Fabry disease: Disease severity, pain, fatigue and psychological distress
Material Type:
Article 		Add to My Research

Health‐related quality of life in Norwegian adults with Fabry disease: Disease severity, pain, fatigue and psychological distress

JIMD reports, 2021-11, Vol.62 (1), p.56-69 [Peer Reviewed Journal]

2021 The Authors. published by John Wiley & Sons Ltd on behalf of SSIEM. ;2021 The Authors. JIMD Reports published by John Wiley & Sons Ltd on behalf of SSIEM. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;ISSN: 2192-8312 ;ISSN: 2192-8304 ;EISSN: 2192-8312 ;DOI: 10.1002/jmd2.12240 ;PMID: 34765399

Full text available

Citations Cited by
4
Delivery is key: lessons learnt from developing splice‐switching antisense therapies
Delivery is key: lessons learnt from developing splice‐switching antisense therapies
Material Type:
Article 		Add to My Research

Delivery is key: lessons learnt from developing splice‐switching antisense therapies

EMBO molecular medicine, 2017-05, Vol.9 (5), p.545-557 [Peer Reviewed Journal]

2017 The Authors. Published under the terms of the CC BY 4.0 license ;2017 The Authors. Published under the terms of the CC BY 4.0 license. ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1757-4676 ;ISSN: 1757-4684 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201607199 ;PMID: 28289078

Full text available

Citations Cited by
5
Associations between severe co‐morbidity and muscle measures in advanced non‐small cell lung cancer patients
Associations between severe co‐morbidity and muscle measures in advanced non‐small cell lung cancer patients
Material Type:
Article 		Add to My Research

Associations between severe co‐morbidity and muscle measures in advanced non‐small cell lung cancer patients

Journal of cachexia, sarcopenia and muscle, 2019-12, Vol.10 (6), p.1347-1355 [Peer Reviewed Journal]

2019 The Authors Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders ;2019 The Authors Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. ;2019. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;ISSN: 2190-5991 ;EISSN: 2190-6009 ;DOI: 10.1002/jcsm.12469 ;PMID: 31385663

Full text available

Citations Cited by
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait